More than 102 million people in the United States have high cholesterol1, which increases the risk of heart disease and stroke. That is why people were hopeful when the cholesterol-lowering drug Crestor was approved by the U.S. Food and Drug Administration.
Although countless people took Crestor to lead healthier lives and drugmaker AstraZeneca made billions of dollars, Crestor was not as safe as patients believed. In the following years, more and more serious side effects were linked to the cholesterol medication.
Patients have fought back against the makers and distributors of Crestor by filing lawsuits with claims that they knew about the risks associated with the drug but failed to warn consumers. They also allege AstraZeneca promoted Crestor in false or misleading ways.